Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes

摘要

The current invention relates to a series of rifamycin derivatives having antimicrobial activities, including activities against drug-resistant microorganisms, specifically, the 3,4-cyclo-rifamycin derivatives having an oxime group at the C-11 position.